AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023

    Date:

    Agile Therapeutics (NASDAQ:AGRX) just reported results for the fourth quarter of 2023.

    • Agile Therapeutics reported earnings per share of -$1.46. This was below the analyst estimate for EPS of -92 cents.
    • The company reported revenue of $3.62 million.
    • This was 11.18% worse than the analyst estimate for revenue of $4.07 million.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Go Source

    Chart

    Sign up for Breaking Alerts

    Share post:

    Popular

    More like this
    Related

    California Leads The Charge: Golden State Now Has 1 EV Charger For Every 5 Gas Stations

    Loading... Loading... In a significant development for California’s electric vehicle infrastructure, the Golden...

    Trump Vs Biden: New Poll Reveals Shift In 2024 Race As Public Divided On Presidents’ Legacies

    Loading... Loading... In a recent CNN poll, former President Donald Trump is found...

    Wait No More: Google Play Store Launches Parallel App Downloads

    Loading... Loading... Alphabet Inc.’s GOOG GOOGL Google Play Store has introduced...

    Why Tesla Rival BYD Charges Up To 3x More For EVs In Europe While China Prices Remain Shockingly Low

    Loading... Loading... While fears of a Chinese EV invasion grip the...